The aim is to evaluate the impact of various treatments on exercise capacity and arrhythmia risk in individuals with obstructive hypertrophic cardiomyopathy.
Randomized trial design analyzing treatment effects on exercise capacity in patients with hypertrophic cardiomyopathy.
Assessment of myocardial hypertrophy and ejection fraction pre- and post-intervention.
Monitoring for arrhythmias during and after exercise testing.
Improvement in exercise capacity by 30% in the treatment group compared to the control group (p=0.02).
Reduction in arrhythmic events observed in 40% of treated patients (p=0.01).
Ejection fraction increased significantly by 5% in the treatment arm (95% CI 2-8, p=0.03).